$ASX

Taiwan's ASE Tech raises 2026 capex by $2 billion on strong demand

ASE Technology Holding said it will raise 2024 capex by $2 billion to about $10.5 billion due to strong demand. The increase is split between $1 billion for facilities and $1 billion for equipment. It expects LEAP revenue to track ahead of 2026 guidance of $3.5 billion and aims to double LEAP revenue in 2027. Q2 revenue rose to T$191.06 billion and net income to T$21.068 billion.

Original reporting
Published Jul 31, 2026, 7:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 8:17 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Taiwan's ASE Tech raises 2026 capex by $2 billion on strong demand — source image
Decision brief

The 30-second read

$ASXBullishMed
01

Why it matters

The capex increase and LEAP revenue tracking ahead of prior guidance provide a concrete demand and scaling signal, while the 2027 doubling target sets expectations for continued customer pull-through.

02

Market read

Traders can update ASE’s demand and capacity outlook using the new capex plan and LEAP revenue trajectory, which may affect near-term estimates and risk premium.

03

What to watch

The article does not quantify customer concentration, utilization assumptions, or capex payback timing, which could matter for valuation despite revenue momentum.

Relevance 8/10Novelty 8/10Timing: guidance update reported pre-market/Thursday ahead of next earnings release

Background

ASE Technology is a leading chip packaging and testing provider, with a focus on advanced packaging (LEAP) used in AI-related chips.

Company-level read

Ticker impact

$ASXBullishMedium confidence
Context

ASE Technology raised 2026 capex guidance by $2 billion to about $10.5 billion, citing strong demand and AI-driven packaging needs.

Expected impact

Likely supportive for the stock on continued demand confirmation, but volatility possible if capex intensity outpaces customer ramps.

Evidence & confidence

The article provides fresh, quantified capex guidance and LEAP revenue tracking ahead of prior 2026 guidance, plus a 2027 doubling target.

Market effects

Signals continued investment in advanced packaging capacity, reinforcing demand expectations across AI hardware supply chain.

Supports Taiwan semiconductor equipment and services sentiment via higher local capex and capacity expansion.

Reinforces global AI chip supply chain tightness, particularly in advanced packaging and testing throughput.

Counterpoint

Capex acceleration can pressure free cash flow and raise execution risk if customer qualification or AI chip demand normalizes.

Key entities

  • ASE Technology Holding

    Raised 2026 capex guidance to about $10.5 billion and said LEAP revenue is tracking ahead of prior 2026 guidance.

  • Siliconware Precision Industries (SPIL)

    Major packaging supplier for Nvidia's AI chips, mentioned as part of ASE's ecosystem.

  • Joseph Tung

    CFO who stated ASE aims to double LEAP business revenue in 2027.

Related articles

$ASXMedAI 8/10

ASE (ASX) Q2 2026 Earnings Call Transcript

ASE Technology Holding Co. reported Q2 2026 revenue of TWD 191.1B (+10% sequential, +27% YoY) and net income of TWD 21.1B (+49% sequential, +180% YoY). ATM revenue was TWD 126.1B, gross margin 27.3%. Management raised annual CapEx guidance to $10.5B and guided Q3 revenue +21% to +22% sequential.

$ASXMed

ASE Technology Q2 Earnings Call Highlights

ASE Technology (NYSE:ASX) reported Q2 EMS revenue of TWD 65.8B, up 6% sequentially and 12% YoY, but gross margin fell to 8.9% and operating margin to 2.4% due to product mix and higher component costs. Q3 guidance calls for 21% to 22% NTD revenue growth and 11.5% to 12.5% operating margin. Capex rises toward 2026.

$ASXMed

Larvotto digs in as Hammer takeover battle heats up

Larvotto Resources defended its June scheme to acquire Hammer Metals after Austral Resources made a competing indicative all-scrip proposal. Larvotto said Austral’s offer is non-binding and would require due diligence and deal documents. Hammer shareholders would get 1 Larvotto share for 22 Hammer shares, valuing it at 5.6c. Glencore backed Larvotto with $15m and a 7-year gold concentrate offtake.

$ASXMedAI 8/10

ASX Admits Misleading Conduct On CHESS Project, To Pay A$20.5 Mln Penalty In Settlement With ASIC

ASX Limited said it has settled ASIC proceedings over misleading statements made in 2022 about the CHESS replacement project. ASX admitted contravening ASIC Act provisions, including a “progressing well” representation. The settlement requires a A$20.5 million penalty plus A$3 million toward ASIC legal costs, subject to Federal Court approval, ending the trial.

$ASXMed

ASX to pay $20.5m penalty for misleading market

ASX Ltd will pay a $20.5m penalty and $3m in ASIC legal costs to settle claims it made a misleading statement about its CHESS clearing and settlement upgrade, according to ASIC. ASIC says ASX told investors in Feb 2022 the project was “progressing well,” then later flagged a likely delay. ASX scrapped the project and wrote off $245m–$255m; the settlement avoids trial pending Federal Court approval.